CTMX
CytomX TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
CTMX vs peer average
81/100
CTMX vs. peer average (A vs. C)
Grade spread
A 1 · B 4 · C 2 · D 3 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
LXEO is the first available peer comparator.
Clinical-stage small-cap biotech with similar financing and milestone sensitivity; useful as a runway/readout comparator, though not a direct mechanistic peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CTMX
CytomX Therapeutics
LXEO
Lexeo Therapeutics
Grade
A
F
Momentum
43
8
Value
52
41
Sentiment
91
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs LXEO
CTMX / LXEO
Grade Position
Above peers
CTMX vs. peer average (A vs. C)
81/100
Momentum
43
CTMXValue
52
CTMXSentiment
91
CTMXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CTMX
LXEO is the first peer returned for this comparison set.